Acute Investment Advisory’s ProShares Ultra MidCap400 MVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-17,508
Closed -$1.24M 50
2021
Q4
$1.24M Buy
+17,508
New +$1.2M 0.9% 34

Other funds holding MVV

Acute Investment Advisory's MVV Position: Q1 2022 in Review

Acute Investment Advisory sold out of ProShares Ultra MidCap400 (MVV) in Q1 2022, closing a stake of 17,508 shares — an estimated $1.24M sold.

Acute Investment Advisory first reported a position in MVV in Q4 2021 and held it in 1 quarter. The position peaked at $1.24M in Q4 2021. 28 funds tracked by Wall St. Rank hold MVV as of Q1 2022.

  • Acute Investment Advisory reported no remaining ProShares Ultra MidCap400 position as of Q1 2022 after selling out during the quarter.
  • Acute Investment Advisory sold 17,508 ProShares Ultra MidCap400 shares in Q1 2022, an estimated $1.24M.
  • Acute Investment Advisory first reported a position in ProShares Ultra MidCap400 in Q4 2021 and held it in 1 quarter.
  • Acute Investment Advisory's ProShares Ultra MidCap400 position peaked at $1.24M in Q4 2021.
  • 28 funds tracked by Wall St. Rank held ProShares Ultra MidCap400 as of Q1 2022.

Based on Acute Investment Advisory's 13F filing for Q1 2022, filed 31 Aug 2022.